<SEC-DOCUMENT>0000935836-24-000779-index.html : 20241223 <SEC-HEADER>0000935836-24-000779.hdr.sgml : 20241223 <ACCEPTANCE-DATETIME>20241223200857 ACCESSION NUMBER: 0000935836-24-000779 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241223 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60487 FILM NUMBER: 241575376 BUSINESS ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE STREET 2: SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE STREET 2: SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Stonepine Capital Management, LLC CENTRAL INDEX KEY: 0001440771 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 BUSINESS PHONE: 541-647-5673 MAIL ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 AGREEMENT <SEQUENCE>2 <FILENAME>ino13g.htm <TEXT> Document 2 - file: ino13g.htm
</DOCUMENT> </SEC-DOCUMENT>